H19 and hepatocellular carcinoma: Oncofetal lncRNA-H19-derived mi-R675could be considered a non-invasive biomarker in place of tissue lncRNA-H19 expression as a potential diagnostic and prognostic marker for HCC as well as a candidate for the development of promising therapeutic targets for HCC.